CUFinder

Stanley Liu

Stanley Liu

University of Toronto

H-index: 38

North America-Canada

Contact Stanley Liu

About Stanley Liu

Stanley Liu, With an exceptional h-index of 38 and a recent h-index of 29 (since 2020), a distinguished researcher at University of Toronto,

His recent articles reflect a diverse array of research interests and contributions to the field:

Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for …

Potentiating salvage radiotherapy in radiorecurrent prostate cancer through anti-CTLA4 therapy: Implications from a syngeneic model

Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer

To boost or not to boost: pooled analyses from 2-fraction SABR trials for localized prostate cancer

Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer

Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

PO59: Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer

Stanley Liu Information

University

Position

Departments of Radiation Oncology and Medical Biophysics

Citations(all)

5668

Citations(since 2020)

3315

Cited By

3744

hIndex(all)

38

hIndex(since 2020)

29

i10Index(all)

76

i10Index(since 2020)

67

Email

University Profile Page

Google Scholar

Top articles of Stanley Liu

Randomized Trial of Concomitant Hypofractionated Intensity Modulated Radiation Therapy Boost Versus Conventionally Fractionated Intensity Modulated Radiation Therapy Boost for …

International Journal of Radiation Oncology* Biology* Physics

2024/5/1

Liying Zhang
Liying Zhang

H-Index: 33

Potentiating salvage radiotherapy in radiorecurrent prostate cancer through anti-CTLA4 therapy: Implications from a syngeneic model

Cancer Research

2024/3/22

Xiaoyong Huang
Xiaoyong Huang

H-Index: 40

Urethra contouring on computed tomography urethrogram versus magnetic resonance imaging for stereotactic body radiotherapy in prostate cancer

Clinical and Translational Radiation Oncology

2024/3/1

Wee Loon Ong
Wee Loon Ong

H-Index: 8

Mark Ruschin
Mark Ruschin

H-Index: 17

Stanley Liu
Stanley Liu

H-Index: 23

To boost or not to boost: pooled analyses from 2-fraction SABR trials for localized prostate cancer

International Journal of Radiation Oncology* Biology* Physics

2023/12/1

Wee Loon Ong
Wee Loon Ong

H-Index: 8

Stanley Liu
Stanley Liu

H-Index: 23

Ananth Ravi
Ananth Ravi

H-Index: 2

Liying Zhang
Liying Zhang

H-Index: 33

Dosimetric correlates of toxicities and quality of life following two-fraction stereotactic ablative radiotherapy (SABR) for prostate cancer

Radiotherapy and Oncology

2023/11/1

Wee Loon Ong
Wee Loon Ong

H-Index: 8

Stanley Liu
Stanley Liu

H-Index: 23

Ananth Ravi
Ananth Ravi

H-Index: 2

Liying Zhang
Liying Zhang

H-Index: 33

Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer

International Journal of Radiation Oncology, Biology, Physics

2023/10/1

Liying Zhang
Liying Zhang

H-Index: 33

The SGLT2 inhibitor canagliflozin suppresses growth and enhances prostate cancer response to radiotherapy

Communications Biology

2023/9/8

Amr Ali
Amr Ali

H-Index: 2

Elham Ahmadi
Elham Ahmadi

H-Index: 4

Stanley Liu
Stanley Liu

H-Index: 23

PO59: Dosimetric Parameters Predictive of Treatment-Related Toxicity in High Dose-Rate Brachytherapy as Monotherapy for Prostate Cancer

Brachytherapy

2023/9/1

Stanley Liu
Stanley Liu

H-Index: 23

Liying Zhang
Liying Zhang

H-Index: 33

Native Mass Spectrometry Quantitation of α2-3-Linked N-Acetylneuraminic Acid Content of Prostate-Specific Antigen: An Accurate Liquid Biopsy for Clinically …

Analytical Chemistry

2023/7/13

Stephanie White
Stephanie White

H-Index: 6

Ultrasound-stimulated microbubbles enhanced vascular disruption in fractionated radiotherapy-treated tumours via ASMase activation

Disease models & mechanisms

2023/6/1

Stanley Liu
Stanley Liu

H-Index: 23

Nanotechnology and machine learning enable circulating tumor cells as a reliable biomarker for radiotherapy responses of gastrointestinal cancer patients

Biosensors and Bioelectronics

2023/4/15

Jiyoon Bu
Jiyoon Bu

H-Index: 10

Stanley Liu
Stanley Liu

H-Index: 23

Andrew Z Wang
Andrew Z Wang

H-Index: 1

Youngsoo Kim
Youngsoo Kim

H-Index: 1

Seungpyo Hong
Seungpyo Hong

H-Index: 34

Two-fraction stereotactic ablative radiotherapy with simultaneous boost to MRI-defined dominant intra-prostatic lesion–Results from the 2SMART phase 2 trial

Radiotherapy and Oncology

2023/4/1

Wee Loon Ong
Wee Loon Ong

H-Index: 8

Stanley Liu
Stanley Liu

H-Index: 23

Ananth Ravi
Ananth Ravi

H-Index: 2

Liying Zhang
Liying Zhang

H-Index: 33

18F-DCFPyL (PSMA) PET as a radiotherapy response assessment tool in metastatic prostate cancer

Clinical and Translational Radiation Oncology

2023/3/1

Elham Ahmadi
Elham Ahmadi

H-Index: 4

Amr Ali
Amr Ali

H-Index: 2

Stanley Liu
Stanley Liu

H-Index: 23

Two-fraction stereotactic MRI-guided ablative radiotherapy with simultaneous boost to dominant intraprostatic lesion: Results from the 2SMART phase 2 trial.

2023/2/20

Wee Loon Ong
Wee Loon Ong

H-Index: 8

Ananth Ravi
Ananth Ravi

H-Index: 2

Liying Zhang
Liying Zhang

H-Index: 33

Three-antibody classifier for muscle invasive urothelial carcinoma and its correlation with p53 expression

Journal of clinical pathology

2022/11/1

Anjelica Hodgson
Anjelica Hodgson

H-Index: 9

Bin Xu
Bin Xu

H-Index: 20

The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors

Nature communications

2022/10/29

Sujun Chen
Sujun Chen

H-Index: 11

Yong Zeng
Yong Zeng

H-Index: 16

Shu Yi Shen
Shu Yi Shen

H-Index: 9

Michael Fraser
Michael Fraser

H-Index: 4

Stanley Liu
Stanley Liu

H-Index: 23

Trevor Pugh
Trevor Pugh

H-Index: 50

Philip Awadalla
Philip Awadalla

H-Index: 50

Guoli Ji
Guoli Ji

H-Index: 23

Felix Feng
Felix Feng

H-Index: 71

Housheng Hansen He
Housheng Hansen He

H-Index: 32

Development of a Clinically Applicable NanoString-Based Gene Expression Classifier for Muscle-Invasive Bladder Cancer Molecular Stratification

Cancers

2022/10/7

Yanhong Yu
Yanhong Yu

H-Index: 11

Katherine Lajkosz
Katherine Lajkosz

H-Index: 7

Success of targeted transperineal biopsy in patients on surveillance for grade group 1 prostate cancer

Canadian Urological Association Journal

2022/8

Stanley Liu
Stanley Liu

H-Index: 23

Two-fraction stereotactic ablative radiotherapy (SABR) versus two-fraction high dose rate (HDR) brachytherapy for localized prostate cancer: Does dose heterogeneity matter?

Radiotherapy and Oncology

2022/4/1

Ananth Ravi
Ananth Ravi

H-Index: 2

Liying Zhang
Liying Zhang

H-Index: 33

Gantry-based 5-fraction elective nodal irradiation in unfavorable-risk prostate cancer: Outcomes from 2 prospective studies comparing SABR boost with MR dose-painted HDR …

International Journal of Radiation Oncology* Biology* Physics

2022/3/1

Ananth Ravi
Ananth Ravi

H-Index: 2

Liying Zhang
Liying Zhang

H-Index: 33

See List of Professors in Stanley Liu University(University of Toronto)

Co-Authors

academic-engine

Useful Links

List of top 50 universities
List of top 100 universities
List of top 500 universities
Find Professors Email
Find Universities Email
CUFinder Academic Engine